367 related articles for article (PubMed ID: 24052077)
1. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma.
Shteinfer-Kuzmine A; Arif T; Krelin Y; Tripathi SS; Paul A; Shoshan-Barmatz V
Oncotarget; 2017 May; 8(19):31329-31346. PubMed ID: 28412744
[TBL] [Abstract][Full Text] [Related]
3. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
4. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity.
Arzoine L; Zilberberg N; Ben-Romano R; Shoshan-Barmatz V
J Biol Chem; 2009 Feb; 284(6):3946-55. PubMed ID: 19049977
[TBL] [Abstract][Full Text] [Related]
5. Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy.
Shteinfer-Kuzmine A; Amsalem Z; Arif T; Zooravlov A; Shoshan-Barmatz V
Mol Oncol; 2018 Jun; 12(7):1077-1103. PubMed ID: 29698587
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Voltage-Dependent Anion Channel 1-Hexokinase-II Complex-Targeted Strategy for Melanoma Inhibition Using Designed Multiblock Peptide Amphiphiles.
Zhang F; Angelova A; Garamus VM; Angelov B; Tu S; Kong L; Zhang X; Li N; Zou A
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35281-35293. PubMed ID: 34309373
[TBL] [Abstract][Full Text] [Related]
7. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
[TBL] [Abstract][Full Text] [Related]
8. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding.
Abu-Hamad S; Zaid H; Israelson A; Nahon E; Shoshan-Barmatz V
J Biol Chem; 2008 May; 283(19):13482-90. PubMed ID: 18308720
[TBL] [Abstract][Full Text] [Related]
9. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.
Shoshan-Barmatz V; Keinan N; Abu-Hamad S; Tyomkin D; Aram L
Biochim Biophys Acta; 2010; 1797(6-7):1281-91. PubMed ID: 20214874
[TBL] [Abstract][Full Text] [Related]
11. The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins.
Abu-Hamad S; Arbel N; Calo D; Arzoine L; Israelson A; Keinan N; Ben-Romano R; Friedman O; Shoshan-Barmatz V
J Cell Sci; 2009 Jun; 122(Pt 11):1906-16. PubMed ID: 19461077
[TBL] [Abstract][Full Text] [Related]
12. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
Ben-Hail D; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
[TBL] [Abstract][Full Text] [Related]
13. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A; Arif T
Front Oncol; 2017; 7():154. PubMed ID: 28824871
[TBL] [Abstract][Full Text] [Related]
14. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G
J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439
[TBL] [Abstract][Full Text] [Related]
15. Oligomerization of the mitochondrial protein VDAC1: from structure to function and cancer therapy.
Shoshan-Barmatz V; Mizrachi D; Keinan N
Prog Mol Biol Transl Sci; 2013; 117():303-34. PubMed ID: 23663973
[TBL] [Abstract][Full Text] [Related]
16. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
Weisthal S; Keinan N; Ben-Hail D; Arif T; Shoshan-Barmatz V
Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
[TBL] [Abstract][Full Text] [Related]
17. The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis.
Keinan N; Pahima H; Ben-Hail D; Shoshan-Barmatz V
Biochim Biophys Acta; 2013 Jul; 1833(7):1745-54. PubMed ID: 23542128
[TBL] [Abstract][Full Text] [Related]
18. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
Arif T; Krelin Y; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
[TBL] [Abstract][Full Text] [Related]
19. VDAC1 functions in Ca
Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A
Cell Calcium; 2018 Jan; 69():81-100. PubMed ID: 28712506
[TBL] [Abstract][Full Text] [Related]
20. Chrysin induces apoptosis in peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia.
Zaric M; Mitrovic M; Nikolic I; Baskic D; Popovic S; Djurdjevic P; Milosavljevic Z; Zelen I
Anticancer Agents Med Chem; 2015; 15(2):189-95. PubMed ID: 25257897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]